KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $11.5 million.

  • Pacific Biosciences Of California's Prepaid Assets fell 3336.23% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year decrease of 3336.23%. This contributed to the annual value of $18.8 million for FY2024, which is 1021.71% up from last year.
  • Pacific Biosciences Of California's Prepaid Assets amounted to $11.5 million in Q3 2025, which was down 3336.23% from $12.3 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Prepaid Assets ranged from a high of $18.8 million in Q4 2024 and a low of $5.6 million during Q1 2021
  • In the last 5 years, Pacific Biosciences Of California's Prepaid Assets had a median value of $13.0 million in 2022 and averaged $12.4 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Prepaid Assets soared by 12858.14% in 2021, and later crashed by 3336.23% in 2025.
  • Pacific Biosciences Of California's Prepaid Assets (Quarter) stood at $7.4 million in 2021, then soared by 39.15% to $10.3 million in 2022, then soared by 65.61% to $17.0 million in 2023, then grew by 10.22% to $18.8 million in 2024, then tumbled by 38.7% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $12.3 million for Q2 2025, and $15.5 million during Q1 2025.